Vedolizumab
Brand name: Entyvio
Rank #449 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$17.4M
Total Cost
2,034
Total Claims
$17.4M
Total Cost
119
Prescribers
$8,531
Cost per Claim
0
Beneficiaries
2,894
30-Day Fills
$146K
Avg Cost/Provider
17
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$17.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $17.4M total
🔎 Data Overview
At $8,531 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $145,817 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Vedolizumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Barry Kaufman | Gastroenterology | Egg Harbor Township, NJ | 54 | $460K |
| 2 | Frederick Weber | Gastroenterology | Birmingham, AL | 43 | $376K |
| 3 | George Christophi | Gastroenterology | Saint Louis, MO | 40 | $353K |
| 4 | Karri Ray | Physician Assistant | Statesboro, GA | 40 | $346K |
| 5 | Kevin Dodd | Gastroenterology | Kingston, NY | 39 | $339K |
| 6 | Susan Fleet | Gastroenterology | Mobile, AL | 36 | $308K |
| 7 | Faiza Bhatti | Gastroenterology | Saint Louis, MO | 35 | $307K |
| 8 | Sarah Glover | Osteopathic Manipulative Medicine | Jackson, MS | 34 | $279K |
| 9 | Thomas Frazier | Gastroenterology | Louisa, KY | 31 | $271K |
| 10 | Ann Shum | Nurse Practitioner | New York, NY | 29 | $260K |
| 11 | Thomas Judge | Gastroenterology | Mount Laurel, NJ | 31 | $257K |
| 12 | Gursimran Kochhar | Gastroenterology | Pittsburgh, PA | 30 | $254K |
| 13 | Thomas Ullman | Gastroenterology | Bronx, NY | 29 | $249K |
| 14 | Kavita Kalra | Hematology-Oncology | Baltimore, MD | 29 | $245K |
| 15 | Richard Geisman | Gastroenterology | Saint Peters, MO | 24 | $243K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 446 | Vismodegib (Erivedge) | $17.4M | 1,317 |
| 447 | Anastrozole (Anastrozole) | $17.4M | 626,025 |
| 448 | Naproxen (Naproxen) | $17.4M | 903,928 |
| 449 | Vedolizumab (Entyvio) | $17.4M | 2,034 |
| 450 | Abatacept/Maltose (Orencia) | $17.2M | 3,809 |
| 451 | Potassium Citrate (Potassium Citrate Er) | $17.1M | 131,481 |
| 452 | Insulin Degludec/Liraglutide (Xultophy 100-3.6) | $17.1M | 10,644 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology